Unique molecules represent a emerging frontier in medicinal development. These particular brief structures of amino units present unprecedented opportunities for targeting previously pathways involved in several Nexaph peptides illnesses. Early studies indicate these can deliver selective affinity and show desirable bioavailability features, creati